S&P 500   5,096.27
DOW   38,996.39
QQQ   439.00
Pure Storage, Hormel Foods rise; WW International, First Advantage fall, Thursday, 2/29/2024
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
How major US stock indexes fared Thursday, 2/29/2024
Average long-term US mortgage rises to 6.94% after marking fourth-straight weekly increase
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Best Buy reports lower 4Q sales and profits as shoppers remain cautious
Grads From This Midwestern School Are More Likely to Start a Billion Dollar Company Than Founders Who Went To Stanford, Harvard, or MIT: Study
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
It's Leap Day, and You're Probably Working — Here's How 'February 29' Affects Your Paycheck
From Hometown Hero to Franchise Partner — 3 Celebrities Collaborating With Their Hometown Brands
S&P 500   5,096.27
DOW   38,996.39
QQQ   439.00
Pure Storage, Hormel Foods rise; WW International, First Advantage fall, Thursday, 2/29/2024
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
How major US stock indexes fared Thursday, 2/29/2024
Average long-term US mortgage rises to 6.94% after marking fourth-straight weekly increase
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Best Buy reports lower 4Q sales and profits as shoppers remain cautious
Grads From This Midwestern School Are More Likely to Start a Billion Dollar Company Than Founders Who Went To Stanford, Harvard, or MIT: Study
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
It's Leap Day, and You're Probably Working — Here's How 'February 29' Affects Your Paycheck
From Hometown Hero to Franchise Partner — 3 Celebrities Collaborating With Their Hometown Brands
S&P 500   5,096.27
DOW   38,996.39
QQQ   439.00
Pure Storage, Hormel Foods rise; WW International, First Advantage fall, Thursday, 2/29/2024
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
How major US stock indexes fared Thursday, 2/29/2024
Average long-term US mortgage rises to 6.94% after marking fourth-straight weekly increase
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Best Buy reports lower 4Q sales and profits as shoppers remain cautious
Grads From This Midwestern School Are More Likely to Start a Billion Dollar Company Than Founders Who Went To Stanford, Harvard, or MIT: Study
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
It's Leap Day, and You're Probably Working — Here's How 'February 29' Affects Your Paycheck
From Hometown Hero to Franchise Partner — 3 Celebrities Collaborating With Their Hometown Brands
S&P 500   5,096.27
DOW   38,996.39
QQQ   439.00
Pure Storage, Hormel Foods rise; WW International, First Advantage fall, Thursday, 2/29/2024
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
How major US stock indexes fared Thursday, 2/29/2024
Average long-term US mortgage rises to 6.94% after marking fourth-straight weekly increase
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Best Buy reports lower 4Q sales and profits as shoppers remain cautious
Grads From This Midwestern School Are More Likely to Start a Billion Dollar Company Than Founders Who Went To Stanford, Harvard, or MIT: Study
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
It's Leap Day, and You're Probably Working — Here's How 'February 29' Affects Your Paycheck
From Hometown Hero to Franchise Partner — 3 Celebrities Collaborating With Their Hometown Brands

Comera Life Sciences (CMRAW) Competitors

$0.0059
+0.01 (+-243.90%)
(As of 02/29/2024 ET)

CMRAW vs. ATNFW, SXTPW, DRTSW, APLMW, ARTLW, BCDAW, BCTXW, CDIOW, CTCXW, and SAVAW

Should you be buying Comera Life Sciences stock or one of its competitors? The main competitors of Comera Life Sciences include 180 Life Sciences (ATNFW), 60 Degrees Pharmaceuticals (SXTPW), Alpha Tau Medical (DRTSW), Apollomics (APLMW), Artelo Biosciences (ARTLW), BioCardia (BCDAW), BriaCell Therapeutics (BCTXW), Cardio Diagnostics (CDIOW), Carmell (CTCXW), and Cassava Sciences (SAVAW). These companies are all part of the "biotechnology" industry.

Comera Life Sciences vs.

180 Life Sciences (NASDAQ:ATNFW) and Comera Life Sciences (NASDAQ:CMRAW) are both medical companies, but which is the better stock? We will compare the two companies based on the strength of their earnings, risk, analyst recommendations, profitability, institutional ownership, dividends, community ranking, media sentiment and valuation.

180 Life Sciences and Comera Life Sciences both received 0 outperform votes by MarketBeat users.

CompanyUnderperformOutperform
180 Life SciencesN/AN/A
Comera Life SciencesN/AN/A

Company Net Margins Return on Equity Return on Assets
180 Life SciencesN/A N/A N/A
Comera Life Sciences N/A N/A N/A

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
180 Life Sciences
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A
Comera Life Sciences
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
180 Life SciencesN/AN/AN/AN/AN/A
Comera Life Sciences$1.00MN/AN/AN/AN/A

In the previous week, 180 Life Sciences had 3 more articles in the media than Comera Life Sciences. MarketBeat recorded 3 mentions for 180 Life Sciences and 0 mentions for Comera Life Sciences. Comera Life Sciences' average media sentiment score of 0.30 beat 180 Life Sciences' score of 0.00 indicating that 180 Life Sciences is being referred to more favorably in the media.

Company Overall Sentiment
180 Life Sciences Neutral
Comera Life Sciences Neutral

Summary

180 Life Sciences beats Comera Life Sciences on 2 of the 3 factors compared between the two stocks.


Get Comera Life Sciences News Delivered to You Automatically

Sign up to receive the latest news and ratings for CMRAW and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CMRAW and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

CMRAW vs. The Competition

MetricComera Life SciencesBiotechnology IndustryMedical SectorNASDAQ Exchange
Market CapN/A$342.80M$4.89B$7.51B
Dividend YieldN/A3.47%2.87%3.86%
P/E RatioN/A227.49273.8718.26
Price / SalesN/A20,919.983,453.79305.48
Price / CashN/A11.2694.5454.73
Price / BookN/A5.224.464.54
Net IncomeN/A-$20.29M$114.20M$211.48M
7 Day PerformanceN/A0.24%4.27%2.63%
1 Month PerformanceN/A4.61%8.77%5.46%
1 Year PerformanceN/A66.50%12.06%8.67%

Comera Life Sciences Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ATNFW
180 Life Sciences
0 of 5 stars
$0.01
flat
N/A-79.4%$0.00N/A0.005Short Interest ↑
Gap Down
SXTPW
60 Degrees Pharmaceuticals
0 of 5 stars
$0.09
+243.1%
N/AN/A$0.00$90,718.000.002Gap Up
DRTSW
Alpha Tau Medical
0 of 5 stars
$0.28
flat
N/A-37.5%$0.00N/A0.0094Short Interest ↑
News Coverage
Gap Down
APLMW
Apollomics
0 of 5 stars
$0.04
+33.6%
N/AN/A$0.00N/A0.0059Short Interest ↑
Gap Up
ARTLW
Artelo Biosciences
0 of 5 stars
$0.02
flat
N/AN/A$0.00N/A0.005Negative News
BCDAW
BioCardia
0 of 5 stars
$0.02
flat
N/AN/A$0.00$570,000.000.0030
BCTXW
BriaCell Therapeutics
0 of 5 stars
$1.43
-4.7%
N/A-39.5%$0.00N/A0.0016Short Interest ↑
Positive News
CDIOW
Cardio Diagnostics
0 of 5 stars
$0.15
+15.7%
N/A-1.7%$0.00$12,705.000.007Short Interest ↓
Gap Up
CTCXW
Carmell
0 of 5 stars
$0.19
flat
N/AN/A$0.00$3.73M0.009Gap Up
SAVAW
Cassava Sciences
0 of 5 stars
$6.05
-11.8%
N/AN/A$0.00N/A0.0026Gap Down

Related Companies and Tools

This page (NASDAQ:CMRAW) was last updated on 3/1/2024 by MarketBeat.com Staff